BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24710934)

  • 1. MicroRNA-215 is a potential prognostic marker for cervical cancer.
    Liang H; Li Y; Luo RY; Shen FJ
    J Huazhong Univ Sci Technolog Med Sci; 2014 Apr; 34(2):207-212. PubMed ID: 24710934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
    Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
    Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
    Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
    BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-335 represents an independent prognostic marker in cervical cancer.
    Wang C; Jiang T
    Tumour Biol; 2015 Aug; 36(8):5825-30. PubMed ID: 25712373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-138 is a potential biomarker and tumor suppressor in human cervical carcinoma by reversely correlated with TCF3 gene.
    Li H; Sheng Y; Zhang Y; Gao N; Deng X; Sheng X
    Gynecol Oncol; 2017 Jun; 145(3):569-576. PubMed ID: 28385388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
    Li M; Li BY; Xia H; Jiang LL
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer.
    Shen SN; Wang LF; Jia YF; Hao YQ; Zhang L; Wang H
    Diagn Pathol; 2013 Apr; 8():69. PubMed ID: 23631806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of microRNA-126 is associated with poor prognosis in patients with cervical cancer.
    Yang Y; Song KL; Chang H; Chen L
    Diagn Pathol; 2014 Dec; 9():220. PubMed ID: 25551621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance and functions of microRNA-93/CDKN1A axis in human cervical cancer.
    Zhang X; Li F; Zhu L
    Life Sci; 2018 Sep; 209():242-248. PubMed ID: 30098344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis.
    He S; Liao B; Deng Y; Su C; Tuo J; Liu J; Yao S; Xu L
    BMC Cancer; 2017 Oct; 17(1):673. PubMed ID: 28978307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
    Luo M; Shen D; Zhou X; Chen X; Wang W
    Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulated microRNA-155 expression is associated with poor prognosis in cervical cancer patients.
    Fang H; Shuang D; Yi Z; Sheng H; Liu Y
    Biomed Pharmacother; 2016 Oct; 83():64-69. PubMed ID: 27470551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of miR-503 is associated with poor prognosis in cervical cancer.
    Yin ZL; Wang YL; Ge SF; Guo TT; Wang L; Zheng XM; Liu J
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4081-5. PubMed ID: 26592830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A.
    Wang N; Zhou Y; Zheng L; Li H
    Gynecol Oncol; 2014 Jul; 134(1):129-37. PubMed ID: 24793973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of low DICER expression regulated by miR-130a in cervical cancer.
    He L; Wang HY; Zhang L; Huang L; Li JD; Xiong Y; Zhang MY; Jia WH; Yun JP; Luo RZ; Zheng M
    Cell Death Dis; 2014 May; 5(5):e1205. PubMed ID: 24787017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of miR-20a and miR-203 in cervical cancer.
    Zhao S; Yao DS; Chen JY; Ding N
    Asian Pac J Cancer Prev; 2013; 14(4):2289-93. PubMed ID: 23725129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-205 serves as a prognostic factor and suppresses proliferation and invasion by targeting insulin-like growth factor receptor 1 in human cervical cancer.
    Pang H; Yue X
    Tumour Biol; 2017 Jun; 39(6):1010428317701308. PubMed ID: 28651495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A microRNA expression signature for cervical cancer prognosis.
    Hu X; Schwarz JK; Lewis JS; Huettner PC; Rader JS; Deasy JO; Grigsby PW; Wang X
    Cancer Res; 2010 Feb; 70(4):1441-8. PubMed ID: 20124485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.